Harvard Bioscience Inc.
HBIO | NASDAQ
$8.90
+$0.10 (+1.14%)
At close: Oct 30, 2026, 4:00 PM ET
$8.90
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 7:30 PM ET
+1.14%
(1D)No price chart data available for 1D timeframe.
Rating
36.2
+3.0 ptsFundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #623/1028 (Top 61%)
Key Statistics
Market Data
Market Cap $40.52M
1D Range
8.80 8.92
52W Range
4.31 8.92
Valuation (TTM)
PE -3.82
PB 5.46
EV/EBITDA -83.30
Valuation (NTM)
Forward PE 12.72
Forward PEG 0.02
Price Target $38.00
Cash Flow
FCF Yield -3.5%
SBC Adj. FCF Yield -6.0%
SBC Impact -73.7%
Margins
Gross Margin 58.2%
Operating Margin 1.2%
FCF Margin -1.6%
Growth (CAGR)
Revenue 3Y | 5Y -8.4% |
-4.6%
Dil EPS 3Y | 5Y 1.4% |
-35.9%
FCF 3Y | 5Y -124.8% |
13.4%
Returns
ROA -13.7%
ROE -92.0%
ROIC 1.9%
Financial Health
Net Debt
$30.18M
Current Ratio 1.87
Interest Coverage 0.30
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationall...
Sector Healthcare
Industry Medical - Instruments & Supplies
Employees 328
IPO Date Dec 7, 2000
Website www.harvardbioscience.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
1
Consensus
Hold
Price Target
$38.00
Upside
+326.97%
Buy (0)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove HBIO